Suja Life Q1 Sales Jump 22.5% to $107.1M, Adjusted EBITDA Rises 66%
SUJA•Suja Life’s Q1 2026 net sales rose 22.5% to $107.1 million, with Adjusted EBITDA up 66.3% to $25.0 million and net income of $7.7 million versus a prior-year loss. The company initiated fiscal 2026 guidance targeting $367–371 million in sales and $70–72 million in Adjusted EBITDA.
1. Q1 2026 Financial Performance
Suja Life generated net sales of $107.1 million in the quarter, a 22.5% increase from the prior year, while gross margin expanded to 50.5%. Adjusted EBITDA rose 66.3% to $25.0 million and net income reached $7.7 million versus a $0.8 million loss in Q1 2025.
2. Balance Sheet Strength and IPO Use of Proceeds
The company completed an IPO pricing 8.9 million shares at $21.00 per share, raising $173.6 million net of underwriting discounts. A portion of proceeds reduced term loan borrowings to $164.9 million, leaving cash and equivalents of $28.4 million and total debt of $303.5 million as of March 30, 2026.
3. Fiscal 2026 Outlook
Suja Life forecasts full-year net sales of $367–371 million, up 12.4%–13.6%, and Adjusted EBITDA of $70–72 million, up 72.8%–77.7%, driven by continued volume growth, distribution gains and promotional effectiveness.
